WAYNE, Pa. (May 17, 2007) - Kenexa® (Nasdaq: KNXA), a leading provider of talent acquisition and retention solutions, today announced that it has received a “Positive” rating in Gartner’s “MarketScope for Employee Performance Management Software, 2007(1).” Kenexa was one of 28 vendors evaluated in the report.
Kenexa offers recruitment, performance, compensation and succession management solutions on the J2EE platform that are delivered as software-as-a-service.
In announcing Kenexa’s evaluation in the report, Rudy Karsan, Chief Executive Officer, said, “We’re honored to receive the “positive” rating that Gartner bestowed upon vendors considered in the 2007 MarketScope report. We believe their positive rating of our performance management solutions validates the depth and breadth of our offerings, which are further differentiated by tailored content and services to help our clients craft their world-class talent management strategies.”
Evaluation criteria for inclusion in the MarketScope included marketing strategy, product strategy, business model, product or service, overall viability, sales executive and pricing, and customer experience. Gartner focused on providers that have a broad, cross-industry solution and production proven products in at least one of three major categories, i.e., performance management, succession management and compensation management. Providers had to demonstrate that they possessed at least 25 customers, 15 of which were production customers that are live with more than 1,000 employees in one category.
The MarketScope is copyrighted 2007 by Gartner, Inc. and is reused with permission. The MarketScope is an evaluation of a marketplace at and for a specific time period. It depicts Gartner’s analysis of how certain vendors measure against criteria for that marketplace, as defined by Gartner. Gartner does not endorse any vendor, product or service depicted in the MarketScope, and does not advise technology users to select only those vendors with the highest rating. Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.